198 related articles for article (PubMed ID: 15297189)
1. Identification of a novel mechanism of NF-kappaB inactivation by progesterone through progesterone receptors in Hec50co poorly differentiated endometrial cancer cells: induction of A20 and ABIN-2.
Davies S; Dai D; Feldman I; Pickett G; Leslie KK
Gynecol Oncol; 2004 Aug; 94(2):463-70. PubMed ID: 15297189
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulatory and transcriptional effects of progesterone through progesterone A and B receptors in Hec50co poorly differentiated endometrial cancer cells.
Davies S; Dai D; Wolf DM; Leslie KK
J Soc Gynecol Investig; 2004 Oct; 11(7):494-9. PubMed ID: 15458748
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel A20-binding inhibitor of nuclear factor-kappa B activation termed ABIN-2.
Van Huffel S; Delaei F; Heyninck K; De Valck D; Beyaert R
J Biol Chem; 2001 Aug; 276(32):30216-23. PubMed ID: 11390377
[TBL] [Abstract][Full Text] [Related]
4. ABINs: A20 binding inhibitors of NF-kappa B and apoptosis signaling.
Verstrepen L; Carpentier I; Verhelst K; Beyaert R
Biochem Pharmacol; 2009 Jul; 78(2):105-14. PubMed ID: 19464428
[TBL] [Abstract][Full Text] [Related]
5. Progesterone inhibits human endometrial cancer cell growth and invasiveness: down-regulation of cellular adhesion molecules through progesterone B receptors.
Dai D; Wolf DM; Litman ES; White MJ; Leslie KK
Cancer Res; 2002 Feb; 62(3):881-6. PubMed ID: 11830547
[TBL] [Abstract][Full Text] [Related]
6. Gene regulation profiles by progesterone and dexamethasone in human endometrial cancer Ishikawa H cells.
Davies S; Dai D; Pickett G; Leslie KK
Gynecol Oncol; 2006 Apr; 101(1):62-70. PubMed ID: 16289307
[TBL] [Abstract][Full Text] [Related]
7. Molecular tools to reestablish progestin control of endometrial cancer cell proliferation.
Dai D; Kumar NS; Wolf DM; Leslie KK
Am J Obstet Gynecol; 2001 Apr; 184(5):790-7. PubMed ID: 11303185
[TBL] [Abstract][Full Text] [Related]
8. Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer.
Sasaki M; Dharia A; Oh BR; Tanaka Y; Fujimoto S; Dahiya R
Cancer Res; 2001 Jan; 61(1):97-102. PubMed ID: 11196205
[TBL] [Abstract][Full Text] [Related]
9. Distinct functional differences of human progesterone receptors A and B on gene expression and growth regulation in two endometrial carcinoma cell lines.
Smid-Koopman E; Blok LJ; Kühne LC; Burger CW; Helmerhorst TJ; Brinkmann AO; Huikeshoven FJ
J Soc Gynecol Investig; 2003 Jan; 10(1):49-57. PubMed ID: 12517594
[TBL] [Abstract][Full Text] [Related]
10. Progesterone and calcitriol attenuate inflammatory cytokines CXCL1 and CXCL2 in ovarian and endometrial cancer cells.
Kavandi L; Collier MA; Nguyen H; Syed V
J Cell Biochem; 2012 Oct; 113(10):3143-52. PubMed ID: 22615136
[TBL] [Abstract][Full Text] [Related]
11. Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action.
Kumar NS; Richer J; Owen G; Litman E; Horwitz KB; Leslie KK
Cancer Res; 1998 May; 58(9):1860-5. PubMed ID: 9581825
[TBL] [Abstract][Full Text] [Related]
12. Progesterone-induced inhibition of growth and differential regulation of gene expression in PRA- and/or PRB-expressing endometrial cancer cell lines.
Smid-Koopman E; Kuhne LC; Hanekamp EE; Gielen SC; De Ruiter PE; Grootegoed JA; Helmerhorst TJ; Burger CW; Brinkmann AO; Huikeshoven FJ; Blok LJ
J Soc Gynecol Investig; 2005 May; 12(4):285-92. PubMed ID: 15866122
[TBL] [Abstract][Full Text] [Related]
13. Progesterone receptor isoform identification and subcellular localization in endometrial cancer.
Leslie KK; Stein MP; Kumar NS; Dai D; Stephens J; Wandinger-Ness A; Glueck DH
Gynecol Oncol; 2005 Jan; 96(1):32-41. PubMed ID: 15589577
[TBL] [Abstract][Full Text] [Related]
14. Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium.
Arnett-Mansfield RL; deFazio A; Wain GV; Jaworski RC; Byth K; Mote PA; Clarke CL
Cancer Res; 2001 Jun; 61(11):4576-82. PubMed ID: 11389093
[TBL] [Abstract][Full Text] [Related]
15. Combined expression of A1 and A20 achieves optimal protection of renal proximal tubular epithelial cells.
Kunter U; Daniel S; Arvelo MB; Choi J; Shukri T; Patel VI; Longo CR; Scali ST; Shrikhande G; Rocha E; Czismadia E; Mottley C; Grey ST; Floege J; Ferran C
Kidney Int; 2005 Oct; 68(4):1520-32. PubMed ID: 16164629
[TBL] [Abstract][Full Text] [Related]
16. Subnuclear distribution of progesterone receptors A and B in normal and malignant endometrium.
Arnett-Mansfield RL; DeFazio A; Mote PA; Clarke CL
J Clin Endocrinol Metab; 2004 Mar; 89(3):1429-42. PubMed ID: 15001645
[TBL] [Abstract][Full Text] [Related]
17. The biology of A20-binding inhibitors of NF-kappaB activation (ABINs).
Verstrepen L; Carpentier I; Beyaert R
Adv Exp Med Biol; 2014; 809():13-31. PubMed ID: 25302363
[TBL] [Abstract][Full Text] [Related]
18. Progesterone receptor A and B expression and progestagen treatment in growth and spread of endometrial cancer cells in nude mice.
Hanekamp EE; Kühne LM; Grootegoed JA; Burger CW; Blok LJ
Endocr Relat Cancer; 2004 Dec; 11(4):831-41. PubMed ID: 15613456
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of long non-coding HOTAIR enhances the sensitivity to progesterone in endometrial cancer by epigenetic regulation of progesterone receptor isoform B.
Chi S; Liu Y; Zhou X; Feng D; Xiao X; Li W; Zhao Y; Wang H
Cancer Chemother Pharmacol; 2019 Feb; 83(2):277-287. PubMed ID: 30443761
[TBL] [Abstract][Full Text] [Related]
20. A20 inhibits human salivary adenoid cystic carcinoma cells invasion via blocking nuclear factor-kappaB activation.
Zhang B; Guan CC; Chen WT; Zhang P; Yan M; Shi JH; Qin CL; Yang Q
Chin Med J (Engl); 2007 Oct; 120(20):1830-5. PubMed ID: 18028781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
